Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Ophthalmology | Genetic Disease
Disease Category: Macular Degeneration
Location: United States, FL
Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration- CEDAR STUDY
This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration.
CW ID: 212055
Date Last Changed:
December 2, 2015
Protocol Number: 150998-005
Susan SherouseUniversity of South Florida- USF Eye Institute13127 Magnolia DriveTampa, FL 33612Phone: 813-974-0948
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.